Adenoma malignum of the uterine cervix: Clinicopathologic analysis of 18 cases

Kaohsiung Journal of Medical Sciences

Kyung-Taek Lim¹  Tae-Jin Kim¹  In-Ho Lee¹  Yong-Soon Kwon²  Soo-Jin Shin³  Jin-Gyu Jeong³ 

[1] Department of Obstetrics and Gynecology, College of Medicine, University of Kwandong, Cheil General Hospital and Women’s Healthcare Center, Korea;Department of Obstetrics and Gynecology, Ulsan University Hospital, University of Ulsan College of Medicine, Dong-gu, Ulsan, Korea;Departments of Anesthesiology and Pain Management, Ulsan University Hospital, College of Medicine, Ulsan University, Ulsan, Korea;

关键词: Adenoma malignum;    Clinicopathologic;    Rare tumor;   

DOI  :  10.1016/j.kjms.2011.10.009

来源: DOAJ

【 摘 要 】

The aim of this study was to evaluate the clinical and pathologic features of a rare tumor (adenoma malignum, AM). We retrospectively analyzed the medical records of 18 patients diagnosed with AM at a single institute between March 1992 and November 2009. The median age of the patients was 45.8 years (range 29–76 years) and the mean follow-up period was 49.2 months (range 4–168 months). A preoperative cytologic diagnosis (Papanicolaou smear) of AM was made in 22.2% (4/18) of the cases. Ten (55.6%) of the 18 patients were misdiagnosed with other benign diseases and underwent hysterectomies, which confirmed AM. Sixteen patients with AM were in the early stage (IB1, 11/18; IB2, 5/18) and the other two patients were in the advanced stage. Fourteen of 18 patients (77.8%) had pure AM alone. Adjuvant therapy was administered to eight of the patients (44.4%) with AM. The recurrence rate was zero, but the disease progressed in two of the patients (11.1%), who died of the disease. The 5-year survival rate was 88.8%. A cytological diagnosis of AM based on a Papanicolaou smear is rarely made; a deep biopsy (cone biopsy or endocervical curettage) is necessary to diagnose this rare tumor preoperatively when there is any clinical suspicion of AM.

【 授权许可】

Unknown